PIH Health First in Los Angeles County and Orange County to Transition to SCOUT MD™ Localization Technology

PIH Health Whittier Hospital has become the first hospital in Los Angeles County and Orange County to transition to SCOUT MD™ localization technology, reinforcing PIH Health's commitment to innovation ...
The Times of Northwest Indiana

Franciscan deploying radar localization technology for breast cancer surgery

Franciscan Health is now deploying wire-free radar localization technology when performing surgery on breast cancer patients. The Franciscan Health Breast Care Center Crown Point has obtained the Savi ...
Nature

Innovative Localization Techniques for Nonpalpable Breast Lesions

Precise localisation of nonpalpable breast lesions is vital for successful breast-conserving surgery, ensuring complete tumour removal while preserving healthy tissue. Conventional wire-guided ...
Nasdaq

RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease

Data presented at this year's San Antonio Breast Cancer Symposium builds on strong base of evidence supporting promise of RaDaR in helping prevent recurrence and improving outcomes FT. MYERS, FL / ...
Nasdaq

NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer

FT. MYERS, FL / ACCESSWIRE / June 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced new data in support of its ...
ascopubs.org

MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET ...

A randomized trial of sentinel node biopsy omission after neoadjuvant systemic therapy in clinically node-negative or selected node-positive breast cancer. This is an ASCO Meeting Abstract from the ...
ascopubs.org

MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET ...

NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer. This is an ASCO Meeting Abstract ...